# FDA Approves Ingenus Pharmaceuticals' Oral Leucovorin Calcium Generic Ingenus Pharmaceuticals, LLC has received FDA approval for oral leucovorin ca...
Financial News Archive
SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
# FDA Approves AstraZeneca's BREZTRI for COPD Treatment AstraZeneca Pharmaceuticals LP received FDA approval for BREZTRI (budesonide, glycopyrrolate,...
# FDA Approves Generic Imatinib Mesylate by BluePoint Laboratories BluePoint Laboratories received FDA approval for its generic formulation of imatin...
The FDA has approved a sublingual formulation of buprenorphine and naloxone hydrochloride dihydrate from Accord Healthcare, expanding access to this e...
Epic Pharma, LLC received FDA approval for its ANDA040910 on July 16, 2020, to manufacture and market generic oxycodone and aspirin in oral tablets. T...
ANI Pharmaceuticals, Inc. announced the acceptance of its Abbreviated New Drug Application (ANDA212252) for acyclovir, a formulation intended for oral...
Quagen has secured FDA approval for its application (ANDA 204649), a move expected to enhance the company's market position by increasing generic supp...
# FDA Approves Taiho Pharmaceutical's INQOVI, First Oral Combination Therapy for Myelodysplastic Syndromes Taiho Pharmaceutical Co., Ltd. received FD...
PHARMOBEDIENT announced final FDA approval for its drug application, a regulatory milestone expected to immediately bolster the company’s competitive ...
# FDA Approves Chartwell Rx Generic Drug Application Chartwell Rx has received FDA approval for its abbreviated new drug application (ANDA 207971), e...
# FDA Approves Genentech's PHESGO as First Subcutaneous Combination HER2 Therapy Genentech's FDA approval of PHESGO (pertuzumab, trastuzumab, and hya...
# FDA Approves UCB's Fintepla (Fenfluramine) for Rare Seizure Disorder UCB, Inc. received FDA approval for Fintepla (fenfluramine) oral formulation o...
Micro Labs announced the FDA's approval of its ANDA to market the generic drug, a move that likely broadens its competitive footprint in the therapeut...
ViiV Healthcare announced Tuesday the FDA approval of TIVICAY PD (dolutegravir sodium), the company's long-acting, injectable formulation of the HIV i...
On June 11, 2020, VIELA BIO announced the receipt of FDA approval for a novel therapeutic, signaling the company's expansion into a new pipeline area ...
# FDA Approves Pfizer's NYVEPRIA, Expanding Pegfilgrastim Biosimilar Competition The FDA has approved Pfizer's NYVEPRIA (pegfilgrastim-apgf), a biosi...
# FDA Approves AMIVAS New Drug Application The FDA has approved NDA213036 for AMIVAS, marking a significant expansion of the company's product portfo...
Macleods Pharmaceuticals Limited received FDA approval on May 15, 2020, for the generic drug emtricitabine and tenofovir disoproxil fumarate (ANDA 203...
Eli Lilly and Company received FDA approval for RETEVMO (selmetinib) to treat patients with advanced RET-fusion-positive meningiomas, a significant mi...
The FDA has approved a 600 mg guaifenesin immediate-release tablet application (No. ANDA213420) for CHAIN DRUG MARKETING ASSOCIATION, INC., relieving ...